symbol,statement_type,period_end,line_item,value
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,44486000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-15078000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,17010000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-52044000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,End Cash Position,14733000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,15944000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-1212000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-38348000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,-110000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-40170000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Preferred Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Preferred Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,17010000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,17010000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-15078000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-15078000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-15078000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-59394000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-7350000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,0.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-7350000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-52044000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,0.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-52044000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,96530000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-19086000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-5019000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,50662000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,395419000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-747184000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-108045000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,404272000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,40170000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Deferred Tax,0.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,19449000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Depreciation,19449000.0
AAREYDRUGS.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,61019000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-37161000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-11362000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,731000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,110806000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-7223000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,End Cash Position,15944000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,7058000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,8887000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,55848000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-574000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-43753000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Preferred Stock Issuance,26696000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Preferred Stock Issuance,26696000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,84110000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,84110000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-10631000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,-10631000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-11362000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,731000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-17023000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-9800000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,0.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-9800000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-7223000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,0.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-7223000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,-29938000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-13250000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-124193000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,-19949000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-40360000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Payable,11534000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-58566000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-11997000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,43753000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Deferred Tax,-6657000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,16980000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Depreciation,16980000.0
AAREYDRUGS.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,53429000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-23251000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,42211000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-10440000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,End Cash Position,7058000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,1919000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,5139000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,13540000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-28671000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Preferred Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Preferred Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,42211000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,42211000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,42211000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,4410000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,14850000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,19030000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-4180000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-10440000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,0.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-10440000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,-12811000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-22788000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-94527000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,236855000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,267674000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Payable,168461000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-151352000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-624891000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,28671000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Deferred Tax,
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,15738000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Depreciation,15738000.0
AAREYDRUGS.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,60096000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-17025000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-39786000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,0.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,82320000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-22013000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,End Cash Position,1919000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-2.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,6497000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-4578000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,22534000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,1000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-20001000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Preferred Stock Issuance,82320000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Preferred Stock Issuance,82320000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,82320000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,82320000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-39786000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-39786000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-39786000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,0.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-32100000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,13752000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,-23885000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,0.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-23885000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-21967000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,46000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-22013000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,4988000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-35901000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-99265000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-36117000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-378967000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Payable,2646000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,47767000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,257293000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,20001000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,0.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Deferred Tax,
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,19883000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Depreciation,19883000.0
AAREYDRUGS.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,100271000.0
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1.0
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Preferred Stock Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Preferred Stock Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,0.0
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Deferred Tax,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Depreciation,
AAREYDRUGS.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
